When was Artis BioSolutions founded?

Artis BioSolutions was founded in 2021 and raised its 1st funding round 4 years after it was founded.

Where is Artis BioSolutions located?

Artis BioSolutions is headquartered in Carlsbad, United States.

Is Artis BioSolutions a funded company?

Artis BioSolutions is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Apr 02, 2025.

When was the latest funding round of Artis BioSolutions?

Artis BioSolutions' latest funding was a $***** Seed round on Apr 02, 2025, with participation from 1 investor.

Where does Artis BioSolutions rank among its competitors?

Artis BioSolutions ranks 39th amongst 58 active competitors, of which 14 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Artis BioSolutions, which secured an undisclosed amount in Apr, 2025.

Who are the top competitors of Artis BioSolutions?

Artis BioSolutions' top competitors include Lightcast Discovery, Slingshot Bioscience and HitGen. Among them, Artis BioSolutions secured the most recent funding round in April, 2025.

Artis BioSolutions - 2026 Company Profile, Funding & Competitors

Company Details

Provider of services streamlining genetic medicines and biologics discovery and production. The company specializes in technologies such as nucleic acids, enzymes, peptides, lipid nanoparticles, reagents, and analytical development. It supports drug development from Phase 1 trials to commercial readiness. The team transfers technology, enabling corporate partners and contract manufacturing organizations to commercialize products.

Key Metrics

Founded Year

2021

Location

Carlsbad, United States

Stage

Seed

Latest Funding Round

Seed, Apr 02, 2025, $*****

Investors

Oak HC/FT

Ranked

39^th among 58 active competitors

Investment & Acquisitions

Syngoi & 1 more

Similar Companies

Lightcast Discovery & 58 more

View Artis BioSolutions' full profile

Artis BioSolutions has raised funding over 1 round. Its latest funding round was a Seed round on Apr 02, 2025 for $*****. 1 investor participated in its latest round. Artis BioSolutions has 1 institutional investor.

Here is the list of recent funding rounds of Artis BioSolutions:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 02, 2025	5178538	Seed	1081398	2453398	8243903	9983456

Access funding benchmarks and valuations. Sign up today!

View details of Artis BioSolutions's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Artis BioSolutions include Lightcast Discovery, Slingshot Bioscience and HitGen. Here is the list of Top 10 competitors of Artis BioSolutions, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Lightcast Discovery 2019, Cambridge (United Kingdom), Series B	Provider of advanced single-cell analysis solutions	$107M	M Ventures, The Sir Martin Wood Residue Trust ... & 19 others	61/100
2nd	Slingshot Bioscience 2012, Berkeley (United States), Series A	Developer of next-generation synthetic cells for diagnostics and therapeutics	$46.4M	Northpond Ventures, Arch Venture Partners ... & 2 others	55/100
3rd	HitGen 2012, Lanzhou (China), Public	Developer of DNA encoded libraries for drug discovery	$39.1M	Shiyu, CDH & 2 others	55/100
4th	InterAx Biotech 2016, Villigen (Switzerland), Series A	Arrestin-based biosensors and computational methods for GPCR based drug discovery	$3.19M	Verve Ventures, Venture Kick & 5 others	54/100
5th	StemoniX 2014, San Diego (United States), Acquired	Engineering human brain and nerve models for neurological insights	$33.7M	EvoNexus, Gopher Angels & 19 others	47/100
6th	Sequence Bio 2013, St John s (Canada), Seed	Sequence Bio is a Newfoundland and Labrador biotechnology company striving to improve how we treat diseases and develop medicines.	$5.47M	DCVC, Y Combinator & 5 others	45/100
7th	Vectus Biosystems 2005, Rosebery (Australia), Public	Develops drug discovery platform	-	-	45/100
8th	Aucta Pharmaceuticals 2012, New Brunswick (United States), Seed	Innovating enhanced therapeutics using technology for specialty brand and generic products	-	Shanghai Changjiang Guohong Investment Management, SDIC Venture Capital Management ... & 3 others	41/100
9th	Signal Pharmaceuticals 1993, San Diego (United States), Acquired	Discoverer of drugs to regulate disease-related genes	$12M	Accel, The Vertical Group & 10 others	40/100
10th	ZoBio 2004, Leiden (Netherlands), Acquired	Provider of fragment-based drug discovery services	-	Europa, Libertatis Ergo Holding	40/100
39th	Artis BioSolutions 2021, Carlsbad (United States), Seed	Provider of services streamlining genetic medicines and biologics discovery and production	-	Oak HC/FT	34/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Artis BioSolutions's competitors? Click here to see the top ones

Artis BioSolutions has acquired 2 companies including Syngoi and Landmarkbio. Artis BioSolutions has not made any investments as of now.

Media has covered Artis BioSolutions for a total of 6 events in the last 1 year, 2 of them have been about company updates and 1 about people movement.